Moreover, baicalin was also recorded to harbor the ability to induce the high expression of glutathione-s-transferase (GST), NAD(P)H: quinone oxidoreductase 1 (NQO1), and heme oxygenase 1 (HO1) by upregulating Nrf2 expression, thus achieving its therapeutic effect on NAFLD [13]. Here, NQO1 is linked to metabolic dysfunction-associated steatotic liver disease.